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Introduction
Allergic fungal sinusitis (AFS) was recognised as a distinct
and separate clinical disorder for the first time in 19761 and
it has become increasingly well-defined in the last couple
of decades.2 AFS is known to be a type I hypersensitivity
reaction. AFS patients may present with unilateral or
bilateral nasal polyps3 and are diagnosed by the presence
of distinctive histological findings.2
In 1994, a diagnostic criterion focussed on the
characteristic features of AFS which included
immunological, radiographical and histological features.
These features included type I hypersensitivity, presence of
polyps in sinonasal region, typical features on CT-PNS,
cultures positive for fungus and fungal elements present in
allergic mucin without tissue invasion.4
Geographical location has an impact on AFS incidence,
with higher incidence at more humid areas. Most
commonly it is seen among adolescents and young adults
in second decade of life2. Male and females are affected
equally with ratio of 1:1. Some theories suggest that polyps
develop due to conditions causing chronic inflammation
in nose and PNSs.5
Multiple epidemiological studies found only 1-2% of
patients having nasal polyposis with positive skin prick
test6-8 showing very little evidence to the assumption that
allergy predisposes to nasal polyposis because of the
presence of watery rhinorrhoea and mucosal swelling
along with eosinophils in nasal secretion.9 AFS is a specific
term given due to the association of nasal polyps with
fungal cultures.6,10
Around 5-10% of patients with chronic rhinosinusitis are
diagnosed as AFS cases. The prevalence of AFS in Saudi
Arabia was reported to be 12.1%11 while it was 9.45% in
Iran.12
Lund et al. described a method for radiological staging of
chronic rhinosinusitis based on finding of CT scan with a
maximum score of 24 for both sides combined.13 It has
been accepted and used widely.14 Lu-Myers et al.
concluded that AFS patients had high Lund-Mackay
score.15
The current study was planned to determine the frequency
of AFS in patients with nasal polyps, and to compare the
Lund-Mackay scores of patients with and without AFS.
Patients and Methods
The cross-sectional longitudinal study was conducted at a
tertiary healthcare centre in Karachi, Pakistan, from
December 2016 to November 2018. Exemption was taken
from the ethics review committee of the Aga Khan
University Hospital, Karachi. The sample size was calculated
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using OpenEpi16 calculator with AFS frequency 12.1%11
precision 6% and confidence level 95%. The sample was
raised using non probability consecutive technique.
All patients of either gender with sinonasal polyposis,
diagnosed on the basis of anterior rhinoscopy, rigid
endoscopy and CT-PNS, and undergoing endoscopic sinus
surgery were included. Those having previous history of
surgery and patients with incomplete records were
excluded.
Lund-Mackay scoring based on CT-PNS of each patient was
done by two radiologists and the mean was taken as the
final score. Sinonasal contents removed during surgery
were sent for histopathology and fungal culture to look for
allergic mucin with fungal hyphae and the growth of
fungus. AFS was diagnosed when histopathology showed
allergic mucin with fungal hyphae, and culture was positive
for fungal growth. All patients were followed up for a
minimum duration of 12 months to look for recurrence.
Data was analysed using SPSS 25. Age and Lund-Mackay
scores were expressed as mean and standard deviation.
Qualitative variables, including gender, presence of asthma,
allergy and pets, smoking habit, residence, occupation, AFS
and recurrence, were reported as frequency and
percentages. Effect modifiers, including age, gender,
presence of asthma, allergy and pets, smoking habit,
residence and occupation, were stratified using Chi-square
test. Lund-Mackay scores of non-AFS and AFS patients were
compared using independent t test. P<0.05 was considered
significant.
Results
Of the 114 patients, 61(53.5%) were males. The overall
mean age was 37.3±15.3 years. Of the total, 27(23.7%)
patients had AFS, while the rest were in the category of
chronic hyperplastic rhinosinusitis (Table 1). 
There were 19(83.3%) non-smokers, 87(76.3%) patients had
allergic rhinitis and 19(16.7%) were asthmatic. The presence
of asthma had a significant relationship with AFS (p=0.03),
while the other variables had no significant relationship
with AFS development of AFS (Table 2).
The mean Lund-Mackay score for non-AFS was significantly
lower compared to AFS patients (p<0.01).
Overall recurrence on follow-up was found in 11(9.6%)
cases; 4(36.4%)AFS cases and 7(63.6%)non-AFS. Of all these
cases, 8(72.7%) were managed medically and
3(27.3%)underwent repeat endoscopic sinus surgery.
Discussion
The current study comprised 114 patients with
preoperative diagnosis of sinonasal polyposis. AFS was
proven in 27(23.7%) on the basis of histo-pathological
features and positive fungal cultures.
A study reported 26.7% AFS incidence in patients with
chronic rhinosinusitis.17 An incidence of 7% was reported
among patients with nasal polyps.18 The prevalence of AFS
among patients in Saudi Arabia was reported to be
12.1%.11 Also, a study in Iran reported AFS prevalence of
9.45%.12
The current study followed up on all the patients for a
minimum of 12 months, and 11(9.6%) cases presented with
recurrent disease; 4(36.4%) AFS and 7(63.6%) non-AFS
patients. A study showed recurrence rate to be 19.54%.12 A
retrospective study reported recurrence rate of 60% with a
mean follow-up of 40 months.19 Shorter follow-up period
could be the cause of lower rate of recurrence reported in
the current study. Further, 19(16.7%) cases with sinonasal
polyposis were asthmatic in the current study, with
8(29.6%) being AFS-positive (p=0.03). A study reported
association of asthma with nasal polyposis in 27.5% cases
and only 2(16.7%) were AFS patients (p>0.05)(12). One
study reported association of asthma with sinonasal polyps
in 25(27.5%) patients compared to just 1(9%) with AFS.11
Further, AFS and non-fungal eosinophilic mucin
rhinosinusitis combined may have resulted in high rates of
association with asthma.20
In 27 cases of AFS, aspergillus (A.) species were revealed in
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Table-1: Prevalence of allergic fungal sinusitis (AFS).
Variables n (%)
Allergic mucin with fungal hyphae on histology Positive 27 (23.7)
Negative 87 (76.3)
Fungal Culture Positive 54 (47.4)
Negative 60 (52.6)
Allergic Fungal Sinusitis Positive 27 (23.7)
Negative 87 (76.3)
Table-2: Distribution of risk factors and relationship with allergic fungal sinusitis (AFS).
Risk factors n (%) Allergic Fungal Sinusistis p-value
Positive [n (%)] Negative [n (%)]
Smoker Yes 19 (16.7) 3 (18.7) 16 (81.3) 0.38
No 95 (83.3) 24 (25.2) 71 (74.8)
Allergy Yes 87 (76.3) 21 (24.1) 66 (75.9) 0.83
No 27 (23.7) 6 (22.2) 21 (77.8)
Asthma Yes 19 (16.7) 8 (42.1) 11 (57.9) 0.03
No 95 (83.3) 19 (20) 76 (80)
Pets Yes 30 (26.3) 4 (13.3) 26 (16.7) 0.12
No 84 (73.7) 23 (27.3) 61 (72.7)
Residence Urban 89 (78.1) 20 (23.5) 69 (76.5) 0.56
Rural 25 (21.9) 7 (28) 18 (72)
Occupation Indoor 73 (64) 20 (31.7) 53 (68.3) 0.21
Outdoor 41 (36) 7 (17.1) 34 (82.9)
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25 cases; A. fumigatus in 23 and A. clavatus in 2 cases. One
case revealed chryosporium species and 1 revealed
bipolaris and there was no significant difference in the
clinical course of patients (p>0.05). Similar findings were
reported earlier from the Middle East, while dematiaceous
is the most common found organism in the United
States.11,12,21
In the current study, the mean Lund-Mackay score was 18.8
for AFS patients compared to 13.2 in non-AFS patients.
Similar significant difference was seen in an earlier study.12
Conclusion
The frequency of AFS among patients with nasal polyps
was 23.7% and the mean Lund-Mackay score was
significantly higher in patients with AFS. Findings suggest
that while managing patients with nasal polyps, AFS
possibility should also be considered.
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